Advisor Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$5.54M Sell
58,525
-344
-0.6% -$30.9K 0.04% 383
2019
Q3
$5.12M Buy
58,869
+1,468
+3% +$132K 0.04% 403
2019
Q2
$5.24M Sell
57,401
-2,961
-5% -$251K 0.04% 375
2019
Q1
$5.2M Buy
60,362
+3,995
+7% +$321K 0.04% 366
2018
Q4
$4.34M Buy
56,367
+5,063
+10% +$394K 0.04% 354
2018
Q3
$3.96M Buy
51,304
+9,408
+22% +$695K 0.04% 394
2018
Q2
$2.84M Sell
41,896
-8,012
-16% -$553K 0.04% 418
2018
Q1
$3.62M Sell
49,908
-16,302
-25% -$1.24M 0.05% 343
2017
Q4
$4.98M Buy
66,210
+17,212
+35% +$1.3M 0.07% 263
2017
Q3
$3.77M Buy
48,998
+4,837
+11% +$365K 0.06% 300
2017
Q2
$3.31M Sell
44,161
-3,122
-7% -$221K 0.06% 321
2017
Q1
$3.15M Buy
47,283
+2,370
+5% +$158K 0.06% 320
2016
Q4
$2.93M Buy
44,913
+7,575
+20% +$491K 0.07% 303
2016
Q3
$2.64M Buy
37,338
+3,842
+11% +$280K 0.06% 329
2016
Q2
$2.47M Buy
+33,496
New +$2.31M 0.07% 319

Other funds holding NVS

Advisor Group's NVS Position: Q4 2019 in Review

Advisor Group reduced its Novartis (NVS) stake by 0.58% in Q4 2019, selling an estimated $30.9K and leaving 58,525 shares worth $5.54M. The position accounts for 0.04% of the portfolio, ranked #383.

Advisor Group first reported a position in NVS in Q2 2016 and has held it in 15 quarters since. 1,172 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

  • Advisor Group held 58,525 shares of Novartis worth $5.54M as of Q4 2019.
  • Advisor Group sold 344 Novartis shares in Q4 2019, an estimated $30.9K.
  • Novartis made up 0.04% of Advisor Group's portfolio in Q4 2019, its #383 holding.
  • Advisor Group first reported a position in Novartis in Q2 2016 and has held it in 15 quarters since.
  • 1,172 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.